GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genscript Biotech Corp (HKSE:01548) » Definitions » PS Ratio

Genscript Biotech (HKSE:01548) PS Ratio : 3.99 (As of May. 15, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Genscript Biotech PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Genscript Biotech's share price is HK$12.42. Genscript Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$3.11. Hence, Genscript Biotech's PS Ratio for today is 3.99.

The historical rank and industry rank for Genscript Biotech's PS Ratio or its related term are showing as below:

HKSE:01548' s PS Ratio Range Over the Past 10 Years
Min: 1.99   Med: 11.97   Max: 44.71
Current: 3.99

During the past 10 years, Genscript Biotech's highest PS Ratio was 44.71. The lowest was 1.99. And the median was 11.97.

HKSE:01548's PS Ratio is ranked better than
72.37% of 999 companies
in the Biotechnology industry
Industry Median: 9.04 vs HKSE:01548: 3.99

Genscript Biotech's Revenue per Sharefor the six months ended in Dec. 2023 was HK$1.66. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$3.11.

During the past 12 months, the average Revenue per Share Growth Rate of Genscript Biotech was 33.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 24.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was 25.80% per year.

During the past 10 years, Genscript Biotech's highest 3-Year average Revenue per Share Growth Rate was 32.20% per year. The lowest was 21.50% per year. And the median was 26.40% per year.

Back to Basics: PS Ratio


Genscript Biotech PS Ratio Historical Data

The historical data trend for Genscript Biotech's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genscript Biotech PS Ratio Chart

Genscript Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.38 7.05 18.33 10.70 6.39

Genscript Biotech Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.33 - 10.70 - 6.39

Competitive Comparison of Genscript Biotech's PS Ratio

For the Biotechnology subindustry, Genscript Biotech's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genscript Biotech's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genscript Biotech's PS Ratio distribution charts can be found below:

* The bar in red indicates where Genscript Biotech's PS Ratio falls into.



Genscript Biotech PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Genscript Biotech's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=12.42/3.113
=3.99

Genscript Biotech's Share Price of today is HK$12.42.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genscript Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$3.11.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Genscript Biotech  (HKSE:01548) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Genscript Biotech PS Ratio Related Terms

Thank you for viewing the detailed overview of Genscript Biotech's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Genscript Biotech (HKSE:01548) Business Description

Traded in Other Exchanges
Address
No. 28, Yongxi Road, Jiangning Science Park, Jiangsu Province, Nanjing, CHN, 211100
GenScript Biotech is a China-based provider of life science research services and products. Founded in 2002, it is best known for its gene synthesis capabilities, a widely used service by academics, biotech companies, and pharmaceutical companies around the world. Its business lines include life science research services and products, biologics development services under its ProBio brand, and industrial enzymes under its Bestzyme brand. Finally, it owns 57.1% of Nasdaq-listed Legend Biotech, whose key pipeline asset is a BCMA-targeting CAR-T treatment for multiple myeloma. We estimate that more than two thirds of GenScript's valuation is from its ownership stake in Legend.

Genscript Biotech (HKSE:01548) Headlines

No Headlines